What is the success rate of EECP therapy for patients with Refractory Angina

What is the Success Rate of EECP Therapy for Patients with Refractory Angina: Enhanced External Counterpulsation (EECP) therapy for patients with refractory angina is quite high, demonstrating significant improvements in symptoms and quality of life. Here are the key findings regarding its efficacy:

EECP Therapy Success Rate Among Patients with Refrectory Angina:

1. Angina Class Improvement:

   • A meta-analysis indicated that approximately 85% of patients undergoing EECP therapy experienced a reduction in their angina severity by at least one Canadian Cardiovascular Society (CCS) class after treatment. This suggests that most patients see a meaningful improvement in their symptoms, moving from more severe classifications of angina to milder forms or none at all.

2. Long-Term Outcomes:

   • Studies have shown that about 72% of patients improved from severe angina to no angina or mild angina following EECP therapy. Furthermore, 55% of patients maintained this decrease in angina severity two years post-treatment.

3. Quality of Life Improvements:

   • In addition to symptom relief, many patients report substantial improvements in their overall quality of life after completing EECP therapy. This includes increased exercise tolerance and reduced reliance on medications like nitroglycerin, with 52% of patients discontinuing nitroglycerin use entirely after treatment.

4. Sustained Benefits:

   • Follow-up studies indicate that the benefits of EECP therapy can be sustained over time, with around 70% of patients maintaining improvements in their CCS class at one-year follow-up and about 66% retaining benefits after 3.5 years.

5. Safety and Tolerability:

   • EECP therapy is generally well-tolerated with minimal adverse events reported, making it a safe option for patients who have not responded adequately to conventional treatments or invasive procedures.

Please make sure that, these meta analysis is based on the outcome of EECP Treatment, when the EECP Therapy is Integrated with other treatmsnts, and lifestyle the results are much better and such clinical outcomes are based on most of the observational studies.

Summary:

In summary, EECP therapy has a high success rate for patients with refractory angina, with about 85% experiencing significant symptom relief and improved quality of life. The therapy not only reduces angina frequency but also enhances overall cardiovascular health, making it a valuable treatment option for individuals who are unresponsive to traditional medical management or invasive therapies.